Search

Author/Creator Lee, Samuel S.

6. Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies. (11th June 2020)

Authors:
Yao, Betty B.; Fredrick, Linda M.; Schnell, Gretja; Kowdley, Kris V.; Kwo, Paul Y.; Poordad, Fred; Nguyen, Kinh; Lee, Samuel S.; George, Christophe; Wong, Florence; Gane, Edward; Abergel, Armand; Spearman, Catherine W.; Nguyen, Tuan; Hung Le, Manh; Pham, Thuy TT.; Mensa, Federico; Asselah, Tarik
Editors:
Dore, Gregory
Journal:
Liver international
Issue:
Volume 40:Number 10(2020)
Page Start:
2385
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial. Issue 2 (4th January 2018)

Authors:
Wyles, David; Poordad, Fred; Wang, Stanley; Alric, Laurent; Felizarta, Franco; Kwo, Paul Y.; Maliakkal, Benedict; Agarwal, Kosh; Hassanein, Tarek; Weilert, Frank; Lee, Samuel S.; Kort, Jens; Lovell, Sandra S.; Liu, Ran; Lin, Chih‐Wei; Pilot‐Matias, Tami; Krishnan, Preethi; Mensa, Federico J.
Journal:
Hepatology
Issue:
Volume 67:Issue 2(2018)
Page Start:
514
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Global multi-stakeholder endorsement of the MAFLD definition. (May 2022)

Authors:
Méndez-Sánchez, Nahum; Bugianesi, Elisabetta; Gish, Robert G; Lammert, Frank; Tilg, Herbert; Nguyen, Mindie H; Sarin, Shiv K; Fabrellas, Núria; Zelber-Sagi, Shira; Fan, Jian-Gao; Shiha, Gamal; Targher, Giovanni; Zheng, Ming-Hua; Chan, Wah-Kheong; Vinker, Shlomo; Kawaguchi, Takumi; Castera, Lauren...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 5(2022)
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗